Biotechnology Stocks I Performance Guide: Day One Biopharmaceuticals, Inc. (DAWN)
DAWN has no dividends.
Table and Chart of DAWN Performance
See what a $1,000 investment in DAWN is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| DAWN Returns | |
|---|---|
| Start Date | Jun-30-2021 |
| Start Price | $22.77 |
| End Date | Sep-12-2024 |
| End Price | $13.67 |
| # Prices | 40 |
| Min Date | May-31-2022 |
| Min Price | $6.22 |
| Max Date | Aug-31-2021 |
| Max Price | $27.83 |
| Total Return | -39.96% |
| Annualized Return | -14.19% |
| Current Value of $1,000 Purchase | $600 |
| Number Returns | 780 |
| Average Return | -3.28% |
| Number Profitable Returns | 276 |
| Percent Profitable Returns | 35.38% |
| Number Unprofitable Returns | 504 |
| Percent Unprofitable Returns | 64.62% |
| Profitable to Unprofitable Returns Ratio | 0.55 |
| DAWN Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -7.180 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -287168992 |
| PE to Growth Ratio | None |
| Price to Book | 169.09 |
| PRICE DATA | |
| 52 Week High | $-1.517 |
| 52 Week Low | $18.07 |
| Analyst Target Price | $0 |
| 50-Day Moving Average | $9.67 |
| 200-Day Moving Average | $14.33 |
| FINANCIAL DATA | |
| Revenue per Share | $-1.94 |
| Revenue | $0 |
| Profit Margin | 9.5% |
| Return on Equity | -42.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
DAWN Compare Returns with S&P 500
DAWN Trendline Chart
DAWN Moving Average Chart
DAWN Stock Return Map - See Patterns of Gains and Losses
DAWN Stock Returns/Purchase Dates